EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

Comparative Risk of Injury with Concurrent Use of Opioids and Skeletal Muscle Relaxants

Cheng Chen iD, Sean Hennessy iD, Colleen M Brensinger, Todd A Miano iD, Warren B Bilker, Sascha Dublin, Sophie P Chung iD, John R Horn, Anika Tiwari, Charles E Leonard iD

Clinical Pharmacology & Therapeutics · 2024

DOI: 10.1002/cpt.3248 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Clinical Pharmacology & Therapeutics, 2024. Verfasst von Cheng Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Real-World Effectiveness and Safety of Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, …. Hauptthemen laut MEDLINE: Analgesics, Opioid, Oxycodone, Tramadol. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NIDA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Concurrent use of skeletal muscle relaxants (SMRs) and opioids has been linked to an increased risk of injury. However, it remains unclear whether the injury risks differ by specific SMR when combined with opioids. We conducted nine retrospective cohort studies within a US Medicaid population. Each cohort consisted exclusively of person‐time exposed to both an SMR and one of the three most dispensed opioids—hydrocodone, oxycodone, and tramadol. Opioid users were further divided into three cohorts based on the initiation order of SMRs and opioids—synchronically triggered, opioid‐triggered, and SMR‐triggered. Within each cohort, we used Cox proportional hazard models to compare the injury rates for different SMRs compared to methocarbamol, adjusting for covariates. We identified 349,543, 139,458, and 218,967 concurrent users of SMRs with hydrocodone, oxycodone, and tramadol, respectively. In the oxycodone‐SMR‐triggered cohort, the adjusted hazard ratios (HRs) were 1.86 (95% CI, 1.23–2.82) for carisoprodol and 1.73 (1.09–2.73) for tizanidine. In the tramadol‐synchronically triggered cohort, the adjusted HRs were 0.69 (0.49–0.97) for metaxalone and 0.62 (0.42–0.90) for tizanidine. In the tramadol‐SMR‐triggered cohort, the adjusted HRs were 1.51 (1.01–2.26) for baclofen and 1.48 (1.03–2.11) for cyclobenzaprine. All other HRs were statistically nonsignificant. In conclusion, the relative injury rate associated with different SMRs used concurrently with the three most dispensed opioids appears to vary depending on the specific opioid and the order of combination initiation. If confirmed by future studies, clinicians should consider the varying injury rates when prescribing SMRs to individuals using hydrocodone, oxycodone, and tramadol.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Analgesics, OpioidOxycodoneTramadolHumansRetrospective StudiesMaleFemaleMiddle AgedAdultUnited StatesHydrocodoneProportional Hazards ModelsCohort StudiesMedicaidYoung AdultDrug InteractionsAgedCarisoprodol

Substanzen

Analgesics, OpioidOxycodoneTramadolHydrocodoneCarisoprodol

Autor:innen und Institutionen

  • Center for Real-World Effectiveness and Safety of Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.

ORCID-Profile: Cheng Chen, Sean Hennessy, Todd A Miano, Sophie P Chung, Charles E Leonard

Förderung

  • NIA NIH HHS
  • NIDA NIH HHS

Zitieren

APA

Chen, C., Hennessy, S., Brensinger, C. M., Miano, T. A., Bilker, W. B., Dublin, S., Chung, S. P., Horn, J. R., Tiwari, A., & Leonard, C. E. (2024). Comparative Risk of Injury with Concurrent Use of Opioids and Skeletal Muscle Relaxants. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.3248

Vancouver

Chen C, Hennessy S, Brensinger CM, Miano TA, Bilker WB, Dublin S, et al. Comparative Risk of Injury with Concurrent Use of Opioids and Skeletal Muscle Relaxants. Clinical Pharmacology & Therapeutics. 2024. doi:10.1002/cpt.3248

BibTeX
@article{Chen2024,
  author = {Chen, Cheng and Hennessy, Sean and Brensinger, Colleen M and Miano, Todd A and Bilker, Warren B and Dublin, Sascha and Chung, Sophie P and Horn, John R and Tiwari, Anika and Leonard, Charles E},
  title = {Comparative Risk of Injury with Concurrent Use of Opioids and Skeletal Muscle Relaxants},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2024},
  doi = {10.1002/cpt.3248}
}
Kostenlos starten →